U.S. Eye Care Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

U.S. Eye Care Market Trends and Insights

Aging-Linked Ocular Disease Burden Sustains Multi-Category Demand

The aging population continues to drive the United States eye care market. In 2024, 4.22 million adults were affected by glaucoma, with the older population exceeding 54 million.^{[2]Centers for Disease Control and Prevention, “Glaucoma Prevalence, United States, 2022,” CDC, cdc.gov} Conditions like cataracts, diabetic retinopathy, and age-related macular degeneration also rise with age, requiring ongoing treatment. Companies with diverse portfolios across multiple disease areas are better positioned to mitigate risks from reimbursement changes compared to single-category players.

Screen Time Expands the Dry-Eye and Vision Correction Addressable Market

Screen exposure has become a significant driver for the United States eye care market. Full-time employees averaged 97 hours of weekly screen time in 2025, with 68% reporting digital eye strain and 63% experiencing eye issues, up from 50% the previous year. This trend sustains demand for blue-light-filtering lenses, prescription eyewear, contact lenses, and dry-eye products, while expanding the market to include pediatric care through myopia management and related treatments.

Omnichannel Access and Managed Vision Care Deepen Market Penetration

Distribution convenience is reshaping the United States eye care market. Managed vision care covered 48% of households in 2025, encouraging routine exams, eyewear purchases, and replenishment cycles. Seamless transitions between clinic-based exams, digital prescriptions, and online fulfillment enhance continuity and reorder behavior. Provider-connected omnichannel models outperform purely offline or digital approaches, maintaining the role of eye care professionals.

Primary-Care AI Retinal Screening Expands the Diagnostic Funnel

AI-based retinal screening is expanding the diagnostic reach of the United States eye care market. By January 2025, Sutter Health deployed AI retinal cameras in 28 primary care practices, improving diabetic eye exam compliance from 62% to 68%. Autonomous AI-assisted screenings increase specialist referrals, streamline workflows, and convert silent disease burdens into active treatment demand, enhancing the overall diagnostic funnel.

Coverage Gaps and Cash-Pay Affordability Constrain Utilization

Coverage design remains a significant challenge for the United States eye care market. In 2024, 6.5 million Medicaid enrollees (12%) lived in states without routine adult eye exam coverage, while 14.6 million (27%) lacked coverage for glasses. Vision benefits are often treated as supplemental, making them narrower and prone to network gaps. This limits access for lower-income patients and older adults, delaying exams, eyewear purchases, and follow-ups, leaving a substantial portion of demand unmet.

Ophthalmology and Subspecialty Workforce Bottleneck Caps Service Throughput

Workforce shortages continue to constrain the United States eye care market. By early 2026, 16,290 ophthalmologists were practicing, falling short by 2,310, with a projected shortfall of 7,290 by 2038. Access is uneven, with 55.7% of counties lacking ophthalmologists, impacting rural areas and regions like the Mountain West. Limited specialist availability leads to longer wait times, reduced procedure volumes, and lower utilization of drugs and devices, despite rising disease prevalence.

Segment Analysis

By Product Category: Ocular Health Therapeutics Gain Share in a Multi-Segment Market

In 2025, Vision Correction Products accounted for 51.44% of revenue, making it the largest product category in the United States eye care market. This reflects the widespread use of spectacles, contact lenses, and refractive corrections, supported by routine replacements, screen-related vision issues, and broad clinical and retail access. Ocular Health Products, the fastest-growing segment, is projected to expand at an 8.10% CAGR through 2031, driven by demand for dry-eye therapeutics, anti-VEGF treatments, and premium ocular supplements.

The market is shifting from episodic corrections to recurring disease management. Surgical and Implantable Products are gaining traction, with RxSight achieving 300,000 Light Adjustable Lens implants by April 2026 and Glaukos advancing Epioxa commercialization in Q1 2026. Diagnostics and Monitoring Systems are also growing as AI tools enhance screening access, favoring companies with strong regulatory capabilities and comprehensive portfolios.

By Mode of Purchase: Rx Dominance Holds, While OTC Demand Builds Steadily

Prescribed products represented 73.22% of purchases in 2025, highlighting the dominance of clinically directed categories in the United States eye care market. Prescription eyewear, specialty contact lenses, surgical implants, and retinal therapies rely on licensed practitioners, keeping the Rx channel central. Over-the-Counter products are forecast to grow at an 8.40% CAGR through 2031, driven by consumer spending on dry-eye drops, ocular vitamins, and allergy-related eye care, supported by aging demographics and preventive self-care trends.

The FTC Eyeglass Rule update in September 2024 improved prescription portability, enabling easier transitions across fulfillment channels. Tele-optometry platforms are further enhancing digital prescription workflows. While the Rx channel remains critical for high-value categories, digital prescription mobility supports both OTC and online Rx fulfillment, blurring the lines between prescribed and consumer-directed purchases.

By Distribution Channel: Physical Clinics Lead, While Online Formats Expand the Fastest

Ophthalmology Clinics and Optometry Stores accounted for 38.67% of revenue in 2025, reflecting their role as key distribution channels in the United States eye care market. Patients rely on physical visits for exams, fittings, and high-value product decisions, ensuring the durability of this channel. The Online Channel, however, is the fastest-growing format, with a projected 10.45% CAGR through 2031, driven by the convenience of digital ordering for contact lenses and other products.

While over 80% of prescription frame and ophthalmic lens transactions occurred in person in 2026, hybrid models like those of Warby Parker and National Vision are scaling by combining physical stores with e-commerce. Tele-optometry collaborations, such as 20/20NOW's 2025 partnership with Walmart Vision Centers, are expanding access in underserved areas. Retail pharmacies are also strengthening their role in OTC eye care sales, creating a dual distribution model where convenience categories shift online, while clinical and fit-sensitive categories remain in person.

By Demographic: Adults Lead Revenue, While Geriatric Demand Advances the Fastest

Adults aged 18-64 contributed 55.78% of revenue in 2025, making them the largest demographic in the United States eye care market. This is driven by workplace vision benefits, routine eyewear demand, and screen-induced eye strain, supported by managed vision care coverage. The Geriatric segment is projected to grow at an 8.95% CAGR through 2031, driven by cataract procedures, anti-VEGF therapy, and glaucoma management, which generate sustained demand.

The younger demographic, though smaller in revenue, is gaining strategic importance. Rising screen-related myopia and dry-eye issues are increasing interest in orthokeratology lenses, low-dose atropine therapy, and defocus-based spectacles. The STAR myopia clinical trial, with results published in 2026, is expected to boost pediatric referrals and treatment adoption. The market thus has two growth poles: older adults with higher disease intensity and children with early prevention-led product needs, broadening the long-term patient pipeline.

Geography Analysis

Across the United States, the eye care market operates on a national scale, yet regional demand varies significantly. The South and Southeast face the highest burden, with states like Texas, Georgia, and the Carolinas experiencing elevated diabetes rates. This drives strong demand for diabetic retinopathy screenings and treatments. Florida's aging population further increases the need for cataract surgeries, anti-VEGF injections, and glaucoma management.

In Texas, high clinical demand is offset by affordability challenges. This reflects a broader issue of uneven insurance coverage and underinsurance, which limits access to routine exams and eyewear despite high disease prevalence. Value-driven retail chains play a critical role in converting unmet needs into actual visits and purchases.

The Northeast and West Coast are key regions for premium care adoption and technological advancements. Northeastern states like New York, Massachusetts, New Jersey, and Pennsylvania leverage strong academic and subspecialty networks to drive the use of advanced diagnostics, branded ophthalmic drugs, and premium surgical devices. On the West Coast, California leads in adopting AI-supported screenings through large integrated systems such as Sutter Health.